Outcomes of thoracic endovascular aortic repair with physician-manufactured partial micropore stent grafts for aortic arch pathologies

作者全名：Huang, Junpu; Tian, Hao; Chen, Zheng; Teng, Biyun; Zhao, Yu; Li, Fenghe

作者地址：[Huang, Junpu; Tian, Hao; Chen, Zheng; Teng, Biyun; Zhao, Yu; Li, Fenghe] Chongqing Med Univ, Affiliated Hosp 1, Dept Vasc Surg, 1 Yuanjiagang Youyi Rd, Chongqing 400042, Peoples R China

通信作者：Li, FH (通讯作者)，Chongqing Med Univ, Affiliated Hosp 1, Dept Vasc Surg, 1 Yuanjiagang Youyi Rd, Chongqing 400042, Peoples R China.

来源：JOURNAL OF VASCULAR SURGERY

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:001247146800001

JCR分区：Q1

影响因子：3.9

年份：2024

卷号：79

期号：5

开始页：1005

结束页：1012

文献类型：Article

关键词：Thoracic endovascular aortic repair; Aortic arch pathologies; Partial micropore stent graft; Supra-aortic branches; Patency rate

摘要：Objective: Thoracic endovascular aortic repair (TEVAR) has been used extensively in the management of thoracic aortic diseases. Numerous efforts have been made to enhance clinical outcomes through the use of stent grafts. This study aimed to investigate the effectiveness and safety of physician -manufactured partial micropore stent grafts (PSMGs) in TEVAR. Methods: Between December 2017 and June 2022, data were collected from 56 patients who underwent TEVAR using physician -manufactured PSMGs. The evaluation encompassed technical success, perioperative and follow-up morbidity and mortality, stroke incidence, and branch artery patency. Results: In this investigation, 56 patients received treatment with physician -manufactured PSMGs. Of these patients, 46 were male, with a mean age of 62.1 6 11.2 years. Aortic pathologies comprised aortic dissection (n = 31 [55.4%]), aortic aneurysms (n = 10 [17.9%]), penetrating aortic ulcer (n = 8 [14.3%]), and intramural hematoma (n = 7 [12.5%]). During a median follow-up of 18 months (interquartile range, 13-25 months), the stroke rate, supra -aortic branch patency rate, and endoleak rate were 0%, 100%, and 7.1%, respectively. There were no occurrences of all -cause mortality, stroke, or the necessity for open conversion. Conclusions: TEVAR with physician -manufactured PSMGs is a viable alternative for addressing aortic arch pathologies in pro fi cient medical centers. The approach demonstrates favorable branch patency, a low complication rate, and minimal postoperative mortality. (J Vasc Surg 2024;79:1005-12.)

基金机构：　

基金资助正文：